S1 Ep30: Routine Breast Cancer Screening in Average-Risk Women Younger Than 50 Years
This week's podcast focuses on a review article published in the June issue of the journal ONCOLOGY titled, “Routine Breast Cancer Screening in Average-Risk Women Younger Than 50 Years: Current Paradigms Based on National Guidelines.” CancerNetwork spoke with Anath Ravi, PhD, co-founder and chief science and clinical officer of MOLLI Surgical, and Randy Miles, MD, MPH, an assistant professor in...
30m Aug 16, 2021
30m
S1 Ep29: Examining Evidence Underlying the NCCN Guidelines for Hematologic Malignancies
This week, CancerNetwork review an article published in the July issue of the journal ONCOLOGY titled, “Level of Scientific Evidence Underlying the National Comprehensive Cancer Network Clinical Practice Guidelines for Hematologic Malignancies.” CancerNetwork spoke with Thejaswi Poonacha, MD, MBA, a staff physician and hospitalist in the department of internal medicine at the University of Minn...
15m Aug 02, 2021
15m
S2 Ep7: Kami Maddocks, MD, on Rituximab Rechallenging and Second-Line Therapies for R/R DLBCL
CancerNetwork spoke with Kami Maddocks MD, an associate professor of clinical internal medicine in the Division of Hematology at The Ohio State University, about CD-19 directed agents, avoiding rechallenging with rituximab, and second-line outcomes for transplant-ineligible patients with diffuse large B-cell lymphoma (DLBCL).   Visit cancernetwork.com to check out the first episode of this 3-p...
14m Jul 30, 2021
14m
S1 Ep28: Considering Second-Line Treatment Amidst Evolving Frontline Landscape for Clear Cell RCC
This week, CancerNetwork® examined an article from the June issue of the journal ONCOLOGY® titled “Second-Line Therapies in the Changing Landscape of First-Line Therapies for Metastatic Clear Cell Renal Cell Cancer (https://www.cancernetwork.com/view/second-line-therapies-changing-landscape-first-line-therapies-metastatic-clear-cell-renal-cell-cancer) ” by speaking with one of the authors, Robe...
16m Jul 19, 2021
16m
S2 Ep6: OncView™ Podcast: Updates in Managing Extensive-Stage Small Cell Lung Cancer
As part of its OncView™ video series, CancerNetwork® spoke with Benjamin Levy, MD, of the John Hopkins Sidney Kimmel Comprehensive Cancer Center, to discuss frontline management of extensive-stage small cell lung cancer (SCLC) and the recent updates in the field.   In the video series, Levy discussed the following:   ·      Small Cell Lung Cancer: Risk and Prognosis (https://www.cancernetwo...
35m Jul 16, 2021
35m
S1 Ep27: BPCIA, 4-Letter Suffix Rule, & the Challenges of Biosimilar Prescription
In this episode, CancerNetwork spoke with 2 experts on the topic of biosimilars, Howard Hochster, MD, FACP, Associate Director for Clinical Research at the Rutgers Cancer Institute of New Jersey and Distinguished Professor of Medicine at the Rutgers School of Medicine, and Michael Kane, RPh, BCOP, Executive Director of Oncology Pharmacy Services for RWJBarnabas Health and Director of Pharmacy S...
28m Jul 05, 2021
28m
S2 Ep5: Emerging and Existing Treatment Regimens for Transplant-Ineligible DLBCL
In this episode, CancerNetwork spoke with Gilles Salles, MD, PhD, Chief of the Lymphoma Service at Memorial Sloan Kettering Cancer Center in New York, about recently approved and emerging treatment regimens for transplant-ineligible diffuse large B-cell lymphoma (DLBCL). Salles discussed some of the available treatment options including tafasitamab, CAR T-cell therapies, selinexor, and antibod...
27m Jun 30, 2021
27m
S2 Ep4: OncView Podcast: Front-Line Management of Extensive-Stage SCLC
As part of the OncView video series, CancerNetwork spoke with Mark Socinski, MD, of the AdventHealth Cancer Institute in Orlando, Florida about updates in the management of extensive-stage small cell lung cancer (ES-SCLC). Socinski touched on a number of important aspects of treating this disease, including the existing standards of care, treatment challenges, immunotherapy, IMpower 133 trial, ...
28m Jun 28, 2021
28m
S1 Ep26: Molecular Profiling Practices in Pancreatic Adenocarcinoma
This week, "Oncology Peer Review On-The-Go" discussed an article from the May issue of the journal ONCOLOGY titled “Molecular Profiling Practices in Pancreatic Adenocarcinoma: Academic vs Community Physicians.” CancerNetwork spoke with Christine Chung, DO, from the HCA Swedish Medical Center in Englewood, Colorado, about the molecular profiling patterns she and her colleagues observed in this r...
30m Jun 21, 2021
30m
S2 Ep3: OncView™ Podcast: Management of Relapsed/Refractory Follicular Lymphoma
As part of its OncView™ video series, CancerNetwork® spoke with Sameh Gaballa, MD, of the Moffit Cancer Center, about current and future treatment options, and considerations for patients with relapsed/refractory follicular lymphoma.   In the video series, Gaballa discussed the following: ·      Treatment Options in Relapsed/Refractory Follicular Lymphoma (https://www.cancernetwork.com/view/...
29m Jun 17, 2021
29m
S1 Ep25: Primary Focal Therapy for Localized Prostate Cancer
The May issue of the journal ONCOLOGY featured a review article titled “Primary Focal Therapy for Localized Prostate Cancer: A Review of the Literature.” Sudhir Isharwal, MD, an assistant professor in the Department of Urology at Oregon Health & Science University in Portland, Oregon, discussed the emergence of focal therapies in the last few years for the treatment of patients with localized p...
27m Jun 07, 2021
27m
S1 Ep24: Treatment Considerations for Transplant-Ineligible Multiple Myeloma
The feature article for this episode comes from the April issue of the Journal ONCOLOGY titled “Treatment Considerations for Transplant-Ineligible Multiple Myeloma.” Sarah Holstein, MD, an associate professor of internal medicine in the Division of Oncology & Hematology at University of Nebraska Medical Center in Omaha, Nebraska, spoke about the need for further research into treatment options ...
14m May 24, 2021
14m
S2 Ep2: OncView Podcast: Optimizing Treatment With Extended Adjuvant Therapy for HR+ Breast Cancer
In this special edition of the “Oncology Peer Review On-The-Go” podcast, CancerNetwork spoke with Reshma L. Mahtani, DO, about genomic testing to optimize treatment outcomes in HR-positive breast cancer.
17m May 19, 2021
17m
S2 Ep1: OncView Podcast: Genomic Testing in HR+ Breast Cancer to Guide Therapy in the Extended Adjuvant Setting
In this special edition of the “Oncology Peer Review On-The-Go” podcast, CancerNetwork spoke with Vijayakrishna (VK) Gadi, MD, PhD about the current role of genomic testing in HR-positive breast cancer.
26m May 18, 2021
26m
S1 Ep23: A Critical Interval to Delay Progression of Prostate Cancer
This episode features an article published in the April issue of the Journal ONCOLOGY titled “Focus on Transitional Disease: A Critical Interval to Delay Progression of Prostate Cancer.” The lead author of the research, E. David Crawford, MD, a urologic oncologist, and professor of urology at the University of California San Diego, explained their research into prostate cancer disease states. A...
36m May 10, 2021
36m
S1 Ep22: Integrating PARP Inhibitors Into Advanced Prostate Cancer Therapeutics
This episode features an article published in the Journal ONCOLOGY titled “Integrating PARP Inhibitors Into Advanced Prostate Cancer Therapeutics.” CancerNetwork spoke with the corresponding author, Jun Gong, a medical oncologist at Cedars-Sinai Medical Center, to discuss the 4 PARP inhibitors that have undergone significant investigation for the treatment of patients with metastatic castrate-...
15m Apr 26, 2021
15m
S1 Ep21: 1-on-1 with David Johnson: Enveric's Endocannabinoid Products for Glioblastoma
In this episode, CancerNetwork sat down for a conversation with David Johnson, chairman and CEO of Enveric Biosciences. Johnson gave a thorough background of the biosciences company, and detailed the endocannabinoid products Enveric is developing to positively impact the quality of life for patients with glioblastoma. Don’t forget to subscribe to the "Oncology Peer Review On-The-Go" podcast an...
16m Apr 12, 2021
16m
S1 Ep20: COVID-19, Cancer, and the Potential of mRNA Vaccines
This episode of the "Oncology Peer Review On-The-Go" podcast centers around an article publishing in the April issue of the Journal ONCOLOGY, titled “Messenger RNA Vaccines-Beckoning of a New Era in Cancer Immunotherapy.” The article touches on the recent development of mRNA vaccines approved to combat COVID-19, and how this development offers optimism for the future of mRNA to treat patients w...
27m Mar 29, 2021
27m
S1 Ep19: Impact of Treatment Refusal on Survival for Small Cell Lung Cancer
In this episode, CancerNetwork examines an article from the March issue of the Journal ONCOLOGY titled “Factors Associated With Treatment Refusal and Impact of Treatment Refusal on Survival of Patients With Small Cell Lung Cancer.” The original research article found that treatment refusal among patients with small cell lung cancer was associated with worse survival, and strategies to increase ...
24m Mar 15, 2021
24m
S1 Ep18: 1-on-1 with Richard Schilsky, MD: Molecular Profiling in GI Cancers
This week, CancerNetwork sat down for a 1-on-1 conversation with former Chief Medical Officer and Executive Vice President of ASCO, Richard Schilsky, MD, to discuss ASCO’s 2021 "Advance of the Year," molecular profiling driving progress in gastrointestinal cancers.  Schilsky discussed the progress being made in this field and the top research contributing to the momentum in gastrointestinal ca...
18m Mar 01, 2021
18m
S1 Ep17: Utility of 21-Gene Recurrence Score for Node-Positive Breast Cancer
This week, CancerNetwork examined a review article published in the February issue of the Journal ONCOLOGY titled “Utility of the 21-Gene Recurrence Score in Node-Positive Breast Cancer.”   The piece highlights the existing literature regarding the prognostic and predictive capabilities of the 21-gene recurrence score in patients with node-positive breast cancer, focusing on current practice ...
32m Feb 15, 2021
32m
S1 Ep16: Mediterranean Diet's Association with Localized Prostate Cancer
This week, CancerNetwork spoke with Justin Gregg, MD, about a study published in Cancer titled “Adherence to the Mediterranean diet and grade group progression in localized prostate cancer: An active surveillance cohort.”   Gregg, an assistant professor of urology at The University of Texas MD Anderson Cancer Center and the lead author of the study, explained that the Mediterranean diet was a...
11m Feb 01, 2021
11m
S1 Ep15: Guidelines for Palliative Treatment of Spinal Metastases
In this episode, CancerNetwork speaks with Ashwatha Narayana, MD, a professor and chairman of radiation oncology at Northern West Chester Hospital. Narayana co-authored a review article titled “Guidelines for Palliative Treatment of Spinal Metastases: Choosing Between Stereotactic Body Radiation Therapy and Conventional Fractionation.”    The article published in the January issue of the Jour...
14m Jan 18, 2021
14m
S1 Ep14: 1-on-1 with Che-Kai Tsao, MD: Smoking Cessation and Patient Screening
In the first episode of 2021, CancerNetwork spoke with Che-Kai Tsao, MD, a medical oncologist at Mount Sinai. Tsao discussed smoking cessation, its relation to cancer, and screenings for patients. More, he went into detail regarding the National Cancer Institute-funded smoking cessation program, a program Mount Sinai has been a part of for a number of years.  Don’t forget to subscribe to the "...
11m Jan 04, 2021
11m
S1 Ep13: Recommending Patient-Reported Outcomes of Pain for Cancer Care
In this episode of "Oncology Peer Review On-The-Go", CancerNetwork takes a look at an article publishing in early 2021 for the Journal ONCOLOGY, titled “Patient-Reported Outcomes of Pain and Related Symptoms in Integrative Oncology Practice and Clinical Research: Evidence and Recommendations.” The piece summarizes current and validated patient-reported outcomes (PROs) specific to cancer-relate...
41m Dec 21, 2020
41m
S1 Ep12: 1-on-1 with Zuri Murrell, MD: Colorectal Cancer in Black Patients
In this edition of "Oncology Peer Review On-The-Go," CancerNetwork spoke with Zuri Murrell, MD, for a conversation regarding the rising rates of colorectal cancer for younger individuals, as well as the significantly higher incidence and death rates for black patients of this cancer type.    Murrell, a colorectal surgeon and cancer specialist at Cedars-Sinai, explained that obesity, diabetes,...
33m Dec 07, 2020
33m
S1 Ep11: Fertility Preservation Decision-Making for Adolescents with Cancer
This latest episode of "Oncology Peer Review On-The-Go" looks at an article published in the November issue of the journal ONCOLOGY, titled “Supporting Decision-Making on Fertility Preservation Among Adolescent and Young Adult Women With Cancer.” The piece examines oncofertility, unexpected cancer diagnoses and the decision-making process for young adult patients. For a breakdown of the article...
32m Nov 23, 2020
32m
S1 Ep10: Barriers to Pancreatic Cancer Clinical Trial Enrollment
This episode of "Oncology Peer Review On-The-Go" examines an article published in the October issue of the journal ONCOLOGY, titled “Barriers to Clinical Trial Enrollment in Patients With Pancreatic Adenocarcinoma Who Are Eligible for Early-Phase Clinical Trials.” The piece was written by Rachael Galvin, DO, MPH, Christine Chung, DO, Ella Achenbach, Oliwier Dziadkowiec, PhD, and Shiraj Sen, MD,...
29m Nov 09, 2020
29m
S1 Ep9: Cancer Care Management During the COVID-19 Pandemic
This episode of “Oncology Peer Review On-The-Go” examines an article published in the October issue of the journal ONCOLOGY, titled “Considerations for the Management of Oncology Patients During the COVID-19 Pandemic.” The piece focuses on the management of the coronavirus pandemic and best practices to effectively manage patients with cancer. For detailed information regarding the article, Can...
33m Oct 26, 2020
33m
S1 Ep8: The Psychological Aspect of Patients in Phase 1 Clinical Trials
This episode of "Oncology Peer Review On-The-Go" features an article published in the September issue of the journal ONCOLOGY. The article is titled “Screening for Phase 1 Clinical Trials: An Opportunity to Evaluate Psychological States and Re-educate Patients on Prognosis?” It was written by Sarah Moreland, MD, and Shiraj Sen, MD, PhD, and focuses on physician-patient communication and the psy...
36m Oct 12, 2020
36m
S1 Ep7: Molecular Profiling in Metastatic Colorectal Cancer
This episode of "Oncology Peer Review On-The-Go" examines a review article published in the September issue of the journal ONCOLOGY. The article, “Molecular Profiling in Metastatic Colorectal Cancer,” was written by Samantha Armstrong, MD, Rita Malley, MS, and Benjamin Weinberg, MD. The piece discusses the epidemiology, tumor location, and mutational landscape of metastatic colorectal cancer. F...
24m Sep 28, 2020
24m
S1 Ep6: 1-on-1 with Dr. Michael Randell: New ACS Guidelines for Cervical Cancer
CancerNetwork speaks with Michael Randell, MD, FACOG, of OBGYN Atlanta to learn more about the new cervical cancer screening guidelines released by the American Cancer Society. In the interview, Randell expresses his concerns with the updated guidelines, and details what he recommends to patients. Don’t forget to subscribe to the Oncology Peer Review On-The-Go podcast on Apple Podcasts, Spotif...
9m Sep 14, 2020
9m
S1 Ep5: Is Next-Generation Sequencing a Right for Patients with GI Cancers?
In the latest episode of "Oncology Peer Review On-The-Go," CancerNetwork examines a Q&A piece in the August issue of the journal ONCOLOGY discussing next-generation sequencing for gastrointestinal cancers. The article is titled “Ushering in the Era of Precision Medicine” and it focuses on a conversation with Tanios Bekaii-Saab, MD, of the Mayo Clinic in Phoenix, Arizona.    For a responding p...
33m Aug 31, 2020
33m
S1 Ep4: The COVID-19 Pandemic's Impact on Cancer Screenings
In this week’s episode, CancerNetwork speaks with Christopher McNair, PhD, of the Sidney Kimmel Cancer Center – Jefferson Health for an in-depth discussion on how the COVID-19 pandemic has impacted cancer screenings. Then, CancerNetwork speaks with Lisa Berry Edwards, managing director of external affairs for the PreventCancer Foundation, to talk about their “Back on the Books” initiative worki...
21m Aug 17, 2020
21m
S1 Ep3: Clinical Trials System and the COVID-19 Pandemic
On this week's episode of Oncology Peer Review On-The-Go, CancerNetwork examines an article from the July issue of the journal ONCOLOGY entitled “Oncology Clinical Trials During the COVID-19 Pandemic.” The article was written by Aline Lara, MD, Denis Jardim, MD, PhD, and Diogo Bastos, MD. CancerNetwork spoke with Dr. Lara and Dr. Bastos for an overview of the review article. Then, CancerNetwor...
26m Aug 03, 2020
26m
S1 Ep2: 1-on-1 with Dr. Xu Ji: Mental Health Among Cancer Survivors
In this episode of Oncology Peer Review On-The-Go, CancerNetwork speaks 1-on-1 with Xu Ji, PhD, MSPH, of the Winship Cancer Institute regarding her research entitled "Mental Health Among Nonelderly Adult Cancer Survivors: A National Estimate."
14m Jul 20, 2020
14m
S1 Ep1: Minority Treatment Disparities and Clinical Trial Enrollment
CancerNetwork talks with Christopher Flowers, MD, of the MD Anderson Cancer Center regarding "Strategies for Overcoming Disparities for Patients With Hematologic Malignancies and for Improving Enrollment on Clinical Trials" from the journal ONCOLOGY. Then, Julie Vose, MD, of the University of Nebraska Medical Center gives her perspective on the factors leading to cancer care disparities and th...
18m Jul 06, 2020
18m